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Evaluation of neoadjuvant chemotherapy in patients with gastric cancer referred to the 
oncology clinic of Imam Khomeini Hospital of Ardabil 
Abstract 
Introduction 
Treatment of Gastric cancer depends on the stage of the disease and chemotherapy and 
surgery are included. Recent studies, particularly in Asian countries have shown that 
preoperative chemotherapy on survival and improve surgical outcome was beneficial and the 
results have been encouraging. The aim of this study was to design the study to increase 
survival and improve the lives of our patients. 
Materials and Methods  
Patients with gastric cancer were identified and were studied with inclusion criteria. 
Neoadjuvant chemotherapy are given in 3 preoperational periods. Choice regime was Ajani 
(taxotere 80 mg/m2, Cisplatin 70 mg/m2, 5-FU 750 mg/m2). After chemotherapy, the 
patient's CT scan was performed again and patients who have had a partial response or stable 
condition, surgery were performed. After surgery, the samples were sent for pathologic 
assessment. Patients received 3 courses of chemotherapy just as the same regimen before 
surgery. Finally, after data collection associated with patient's CT scan, the patient's clinical 
condition before and after neoadjuvant chemotherapy, all registered data were transformed 
into SPSS-16 software and analyzed. 
Results 
30 patients, 20 males (66.7%) and 10 females (33.3 %) with gastric cancer were included in 
the analysis. The mean age of patients was 56/70 ± 13/04 years. All patients had 
adenocarcinoma and gastroesophageal junctions (EGJ) with 17 cases (56.7%) were the most 
common sites of tumor occurrence. There were 17 patients (56.7%) in T3 (the tumor size 
(T)), 10 patients (33.3%) in N2 (involvement of lymph nodes (N)) and none in the metastatic 
lesion. After chemotherapy, the tumor size decreased significantly but lymph node 
involvement and metastases showed no significant changes. It was also observed that 9 
patients (30%) patients had 3A. After chemotherapy there were reductions in 15 patients 
(50%), unchanged in 5 patients (16.7%) and increased in 2 patients (6.7%). Initially in the CT 
scan, all patients had normal CT for lymph node of Para aorta and surrounding tissue 
involvement. But after chemotherapy 2 cases showed surrounding tissue and lymph nodes 
involvement (P = 0.150).  
Conclusion 
Based on our study, receiving neoadjuvant chemotherapy was only able to reduce tumor size 
significantly and significant effect on the involvement of lymph node, metastasis was not 
found. Neoadjuvant chemotherapy is generally effective in reducing gastric cancer stage. 
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